Literature DB >> 12018836

DNA-dependent protein kinase complex: a multifunctional protein in DNA repair and damage checkpoint.

Suk-Hee Lee1, Chung-Hui Kim.   

Abstract

DNA-dependent protein kinase (DNA-PK) is a nuclear serine/threonine protein kinase that is activated upon DNA damage generated by ionizing radiation or UV-irradiation. It is a three-protein complex consisting of a 470-kDa catalytic subunit (DNA-PKcs) and the regulatory DNA binding subunits, Ku heterodimer (Ku70 and Ku80). Mouse and human cells deficient in DNA-PKcs are hypersensitive to ionizing radiation and defective in V(D)J recombination, suggesting a role for the kinase in double-strand break repair and recombination. The Ku heterodimer binds to double-strand DNA breaks produced by either DNA damage or recombination, protects DNA ends from degradation, orients DNA ends for re-ligation, and recruits its catalytic subunit and additional factors necessary for successful end-joining. DNA-PK is also involved in an early stage of damage-induced cell cycle arrest, however, it remains unclear how the enzyme senses DNA damage and transmits signals to downstream gene(s) and proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12018836

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  29 in total

1.  The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.

Authors:  Rongtuan Lin; Ryan S Noyce; Susan E Collins; Roger D Everett; Karen L Mossman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 2.  Integrin signalling and the cellular response to ionizing radiation.

Authors:  Nils Cordes; Viktor Meineke
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

3.  Biochemical characterization of metnase's endonuclease activity and its role in NHEJ repair.

Authors:  Brian D Beck; Sung-Sook Lee; Elizabeth Williamson; Robert A Hromas; Suk-Hee Lee
Journal:  Biochemistry       Date:  2011-04-27       Impact factor: 3.162

4.  Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition.

Authors:  Jana Ćmielová; Radim Havelek; Jiřina Vávrová; Martina Řezáčová
Journal:  Med Oncol       Date:  2015-03-24       Impact factor: 3.064

5.  P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.

Authors:  Wuqiang Zhu; Wenjun Zhang; Weinian Shou; Loren J Field
Journal:  Cardiovasc Res       Date:  2014-05-08       Impact factor: 10.787

6.  IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK.

Authors:  Oren J Becher; Katia M Peterson; Soumen Khatua; Maria R Santi; Tobey J MacDonald
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

7.  Bcl-3 regulates UVB-induced apoptosis.

Authors:  Ingrid García; Gabriela Cosío; Floria Lizárraga; Gustavo Martínez-Ruiz; Jorge Meléndez-Zajgla; Gisela Ceballos; Magali Espinosa; Rosario Pacheco; Vilma Maldonado
Journal:  Hum Cell       Date:  2013-03-14       Impact factor: 4.174

8.  Radiosensitization and growth inhibition of cancer cells mediated by an scFv antibody gene against DNA-PKcs in vitro and in vivo.

Authors:  Li Du; Li-Jun Zhou; Xiu-Jie Pan; Yu-Xiao Wang; Qin-Zhi Xu; Zhi-Hua Yang; Yu Wang; Xiao-Dan Liu; Mao-Xiang Zhu; Ping-Kun Zhou
Journal:  Radiat Oncol       Date:  2010-08-12       Impact factor: 3.481

9.  DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine.

Authors:  Jarah A Meador; Yanrong Su; Jean-Luc Ravanat; Adayabalam S Balajee
Journal:  Carcinogenesis       Date:  2009-11-23       Impact factor: 4.944

10.  Enhanced induction of apoptosis in a radio-resistant bladder tumor cell line by combined treatments with X-rays and wortmannin.

Authors:  Trinidad Ortiz; Miguel Angel Burguillos; Guillermo López-Lluch; Plácido Navas; Miguel Herrador; Isabel González; Joaquín Piñero
Journal:  Radiat Environ Biophys       Date:  2008-09-12       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.